Liliana E. Weimer

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Cognitive impairment in long-COVID: frequency, trajectories and risk factors in a cohort study from Italy.

Cognitive impairment in long-COVID: frequency, trajectories and risk factors in a cohort study from Italy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: March 03, 2026

Factors affecting exercise performance at the 6-min walk test in long-COVID: a multicenter study from Italy.

Factors affecting exercise performance at the 6-min walk test in long-COVID: a multicenter study from Italy.

Journal: Internal and emergency medicine

Published: January 22, 2026

New Cardiovascular Diagnoses, Symptoms and Functional Status Following SARS-CoV-2 Infection in a National Cohort of 1,734 Patients in Italy.

New Cardiovascular Diagnoses, Symptoms and Functional Status Following SARS-CoV-2 Infection in a National Cohort of 1,734 Patients in Italy.

Journal: Heart, lung & circulation

Published: December 30, 2025

Dyspnea and fatigue in Long-COVID: definition of risk factors and of DLCO-based phenotypes in a multicenter study of 765 patients from Italy.

Dyspnea and fatigue in Long-COVID: definition of risk factors and of DLCO-based phenotypes in a multicenter study of 765 patients from Italy.

Journal: Respiratory medicine

Published: November 20, 2025

Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms.

Administration of antivirals, IL-6 inhibitors, monoclonal neutralizing antibodies and systemic corticosteroids in acute SARS-CoV-2 infection do not reduce the subsequent burden of Long-COVID symptoms.

Journal: Le infezioni in medicina

Published: July 21, 2025

Persisting or recurrent dermatological manifestations in Long-COVID: Data from a national cohort of 1741 patients from Italy.

Persisting or recurrent dermatological manifestations in Long-COVID: Data from a national cohort of 1741 patients from Italy.

Journal: Journal of the American Academy of Dermatology

Published: June 05, 2025

Persistence of symptoms in long-COVID: follow-up trajectories of 30 symptoms in 755 patients from a national multicenter study from Italy.

Persistence of symptoms in long-COVID: follow-up trajectories of 30 symptoms in 755 patients from a national multicenter study from Italy.

Journal: Internal and emergency medicine

Published: May 09, 2025

Adolescents with Persistent Symptoms Following Acute SARS-CoV-2 Infection (Long-COVID): Symptom Profile, Clustering and Follow-Up Symptom Evaluation.

Adolescents with Persistent Symptoms Following Acute SARS-CoV-2 Infection (Long-COVID): Symptom Profile, Clustering and Follow-Up Symptom Evaluation.

Journal: Children (Basel, Switzerland)

Published: November 13, 2024

Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.

Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.

Journal: BMC medicine

Published: September 18, 2024

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Journal: PloS one

Published: January 03, 2018

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.

Journal: PloS one

Published: July 06, 2017

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.

Journal: PloS one

Published: October 26, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026